License-Out
License Agreement Has Been Entered into with MiCAN Technologies Inc.
We have executed a non-exclusive license agreement with MiCAN Technologies Inc. (Kyoto, Japan) for providing iPS cell-derived cells for rese...
results 31 - 40 of 87
License-Out
License Agreement Has Been Entered into with Roslin Technologies
We have executed a non-exclusive license agreement with Roslin Technologies Ltd (Midlothian, United Kingdom) for providing non-human iPS cel...
License-Out
License Agreement Has Been Entered with Time Therapeutics, Inc.
We executed an exclusive worldwide license agreement with Time Therapeutics, Inc. (Kyoto, Japan) for the development, production and sale of...
License-Out
License Agreement Has Been Entered into with RheinCell Therapeutics
We have executed a non-exclusive license agreement with RheinCell Therapeutics GmbH (Germany) for conducting a GMP-grade iPS cell bank consi...
License-Out
License Agreement Has Been Entered into with Heartseed Inc.
We have executed a worldwide license agreement with Heartseed Inc. (Tokyo, Japan) for the use of iPS cell-derived cardiomyocytes products fo...
License-Out
License Agreement Has Been Entered into with Horizon Discovery
We have executed a non-exclusive license agreement with Horizon Discovery Limited (Cambridge, United Kingdom) for providing in vitro diagnos...
License-Out
License Agreement Has Been Entered with Thyas Co. Ltd.
We executed a worldwide license agreement with Thyas Co. Ltd. (Kyoto, Japan) for the use of iPS cell-derived T cells for autologous immunoth...
License-Out
License Agreement Has Been Entered with Shengshi Rongen Bio-tech
We executed a non-exclusive license agreement with Shengshi Rongen Bio-tech Co., Ltd. (Shanghai, China) for providing their cosmetic product...
License-Out
License Agreement between NACALAI TESQUE, INC. and iPS Academia Japan, Inc.
iPS Academia Japan, Inc. has entered into a non-exclusive license agreement with NACALAI TESQUE, INC. (Kyoto, Japan) to provide products and...
License-Out
License Agreement Has Been Entered with aceRNA Technologies
We executed an exclusive worldwide license agreement with aceRNA Technologies Co., Ltd. (Kyoto, Japan) for providing reagents and services f...
